Phase I/II study of XELOXIRI(CPT-11,L-OHP, capecitabine) with Cetuximab in patients with kras wild type-unresectable advanced/metastatic colorectal cancer
Latest Information Update: 04 Dec 2016
At a glance
- Drugs Cetuximab (Primary) ; Capecitabine; Irinotecan; Oxaliplatin
- Indications Colorectal cancer
- Focus Adverse reactions
- 11 Oct 2016 Results (n=12) presented at the 41st European Society for Medical Oncology Congress
- 08 Nov 2012 New trial record